Balanced cytokine-producing pattern in mice immunized with an avirulent Trypanosoma cruzi

Anais da Academia Brasileira de Ciencias

Volumn 75, Issue 2, 2003, Pages 167-172

  Soares, Milena B P ^a,b   Gonçalves, Renata ^a   Pyrrho, Alexandre S ^a   Costa, Deise A ^a   Paiva, Claudia N ^a   Gattass, Cerli R ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cytokines; Humoral response; Protection; Trypanosoma cruzi

Indexed keywords

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0042762667     PISSN: 00013765     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0001-37652003000200005     Document Type: Article

References (23)

1. BAHIA-OLIVEIRA LM, GOMES JA, ROCHA MO, MOREIRA MC, LEMOS EM, LUZ ZM, PEREIRA ME, COFFMAN RL, DIAS JC, CANCADO JR, GAZZINELLI G AND CORREA-OLIVEIRA R. 1998. IFN-gamma in human Chagas' disease: protection or pathology? Braz J Med Biol Res 31: 127-131.
2. BRODSKYN CI, SILVA AM, TAKEHARA HA AND MOTA I. 1989. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi. Immunol Cell Biol 67: 343-348.
3. CAMARGO MM, ALMEIDA IC, PEREIRA MES, FERGUSON MAJ, TRAVASSOS LR AND GAZZINELLI RT. 1997. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J Immunol 158: 5890-5901.
4. CERBAN F, GRUPPI A AND VOTTERO-CIMA E. 1992. Trypanosoma cruzi: involvement of IgG isotypes in parasitemia control of mice immunized with parasite exoantigens of isoeletric point 4.5. Exp Parasitol 75: 137-145.
5. COSTA F, FRANCHIN G, PEREIRA-CHIOCCOLA VL, RIBERIÃO M, SCHENKMAN S AND RODRIGUES MM. 1998. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16: 768-774.
6. DOSREIS GA. 1997. Cell-mediated immunity in expertmental Trypanosoma cruzi infection. Parasitol Today 13: 335-342.
7. FINKELMAN F, HOMES J, KATONA I, URBAN J, BECKMANN M, PARK L, SCHOOLEY K, COFFMAN R, MOSSMAN T AND PAUL W. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Ann Rev Immunol 8: 303-333.
8. GAZZINELLI RT, OSWALD IP, HIENY S, JAMES SL AND SHER A. 1992. The microbicidal activity of IFN-γ treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by IL-10 and TGF-β. Eur J Immunol 22: 2501-2506.
9. HOFT DF, LYNCH RG AND KIRCHHOFF LV. 1993. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J Immunol 151: 7038-7047.
10. HÖLSCHER C, KÖHLER G, MÜLLER U, MOSSMANN H, SCHAUB GA AND BROMBACHER F. 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66: 1208-1215.
11. LIMA MT, JANSEN AM, RONDINELLI E AND GATTASS CR. 1991. Trypanosoma cruzi: properties of a clone isolated from CL strain. Parasitol Res 77: 77-81.
12. LIMA MT, LENZI HL AND GATTASS CR. 1995. Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi. Parasitol Res 81: 6-12.
13. MEYER-ZUM-BÜSCHENFELDE C, CRAMER S, TRUMPFHELLER C, FLEISHER B AND FRO S. 1997. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-γ) production. Clin Exp Immunol 110: 378-385.
14. MILLER MJ, WRIGHTSMAN RA AND MANNING JE. 1996. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response. Exp Parasitol 84: 156-167.
15. + cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Exp Parasitol 91:7-19.
16. PLANELLES L, THOMAS MC, ALONSO C AND LÓPEZ MC. 2001. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect Immun 69: 6558-6563.
17. PYRRHO A, MORAES JLC, PEÇANHA LMT AND GATTASS CR. 1998. Trypanosoma cruzi: IgG1 and IgG2b are the main immunoglobulins produced by vaccinated mice. Parasitol Res 84: 333-337.
18. REED SG. 1988. In vivo administration of recombinant IFN-gamma induces macrophage activation and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections, J Immunol 140: 4342-4347.
19. RODRIGUES MM, RIBEIRÃO M, PEREIRA-CHIOCCOLA V, RENIA L AND COSTA F. 1999. Predominance of CD4 Th1 and CDS Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect Immun 67: 3855-3863.
20. RD AND HOFT DF. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun 70: 5065-5074.
21. SOARES MBP, SILVA-MOTA KN, LIMA RS, BELLINTANI MC, DECARVALHO LC P AND RIBEIRO-DOS-SANTOS R. 2001. Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. Am J Pathol 159: 703-709.
22. TORRICO F, HEREMANS H, RIVERA MT, VAN MARCK E, BILLIAU A AND CARLIER Y. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146: 3626-3632.
23. ZHANG L AND TARLETON RL. 1996. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol 26: 102-109.